• Fri, May 10, 2024
David Amsellem Reiterated (XERS) at Buy with Decreased Target to $3 on, May 10th, 2024
David Amsellem of Piper Sandler, Reiterated "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Decreased Target from $4 to $3 on, May 10th, 2024.
David has made no other calls on XERS in the last 4 months.
There are 2 other peers that have a rating on XERS. Out of the 2 peers that are also analyzing XERS, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $5 on, Thursday, March 28th, 2024
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 7th, 2024
Like: 👍
